Citation: Rg. Karki et Vm. Kulkarni, Three-dimensional quantitative structure-activity relationship (3D-QSAR) of 3-aryloxazolidin-2-one antibacterials, BIO MED CH, 9(12), 2001, pp. 3153-3160
Citation: Rg. Karki et Vm. Kulkarni, A feature based pharmacophore for Candida albicans MyristoylCoA: protein N-myristoyltransferase inhibitors, EUR J MED C, 36(2), 2001, pp. 147-163
Citation: Vm. Gokhale et Vm. Kulkarni, Understanding the antifungal activity of terbinafine analogues using quantitative structure-activity relationship (QSAR) models, BIO MED CH, 8(10), 2000, pp. 2487-2499
Citation: Vm. Gokhale et Vm. Kulkarni, Selectivity analysis of 5-(arylthio)-2,4-diaminoquinazolines as inhibitorsof Candida albicans dihydrofolate reductase by molecular dynamics simulations, J COMPUT A, 14(5), 2000, pp. 495-506
Citation: Vm. Kulkarni et al., Variability and path analysis in white grain pearl millet [Pennisetum glaucum (L.) R. Br.], TROP AGR, 77(2), 2000, pp. 130-132
Citation: Ss. Kulkarni et al., Three-dimensional quantitative structure activity relationships (3-D-QSAR)of antihyperglycemic agents, BIO MED CH, 7(7), 1999, pp. 1475-1485
Citation: Tt. Talele et al., Development of pharmacophore alignment models as input for comparative molecular field analysis of a diverse set of azole antifungal agents, J CHEM INF, 39(6), 1999, pp. 958-966
Citation: Ss. Kulkarni et Vm. Kulkarni, Structure based prediction of binding affinity of human immunodeficiency virus-1 protease inhibitors, J CHEM INF, 39(6), 1999, pp. 1128-1140
Citation: Ss. Kulkarni et Vm. Kulkarni, Three-dimensional quantitative structure-activity relationship of interleukin 1-beta converting enzyme inhibitors: A comparative molecular field analysis study, J MED CHEM, 42(3), 1999, pp. 373-380
Citation: Vm. Gokhale et Vm. Kulkarni, Comparative molecular field analysis of fungal squalene epoxidase inhibitors, J MED CHEM, 42(26), 1999, pp. 5348-5358